Long‐term efficacy and safety of dichlorphenamide for treatment of primary periodic paralysis

INTRODUCTION/AIM: Long‐term efficacy and safety of dichlorphenamide (DCP) were characterized in patients with primary periodic paralysis (PPP). METHODS: Patients with PPP in a double‐blind, placebo‐controlled study were randomly assigned to receive DCP 50 mg twice daily or placebo for 9 weeks, follo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sansone, Valeria A., Johnson, Nicholas E., Hanna, Michael G., Ciafaloni, Emma, Statland, Jeffrey M., Shieh, Perry B., Cohen, Fredric, Griggs, Robert C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Clinical Research Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290603/
https://www.ncbi.nlm.nih.gov/pubmed/34129236
http://dx.doi.org/10.1002/mus.27354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290603/
https://www.ncbi.nlm.nih.gov/pubmed/34129236
http://dx.doi.org/10.1002/mus.27354

Ejemplares similares